|
⚲
|
| Keyboard |
| Korczynski Sherry
✚
|
|
|---|---|
| CIK # | 0002026090 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0002026090] | |
| 4 | [0002026090] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Korczynski Sherry | |
| Aquestive Therapeutics Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Aquestive Therapeutics Inc AQST
Common Stock
|
2026-03-10 | Sell | 15,741 | $4.17 | 65,640 |
|
Aquestive Therapeutics Inc AQST
Non-Qualified Stock Option (right to buy) · derivative
|
2026-03-09 | Grant | 42,500 | $4.29 | 182,325 |
|
Aquestive Therapeutics Inc AQST
Common Stock
|
2026-03-09 | Grant | 75,000 | $0.00 | |
|
Aquestive Therapeutics Inc AQST
Common Stock
|
2025-08-14 | Grant | 25,000 | $0.00 | |
|
Aquestive Therapeutics Inc AQST
Common Stock
|
2025-06-09 | Tax withheld | 2,714 | $3.54 | 9,608 |
|
Aquestive Therapeutics Inc AQST
Non-Qualified Stock Option (right to buy) · derivative
|
2025-03-07 | Grant | 35,000 | $0.00 | |
|
Aquestive Therapeutics Inc AQST
Common Stock
|
2025-03-07 | Tax withheld | 5,428 | $2.65 | 14,384 |
|
Aquestive Therapeutics Inc AQST
Common Stock
|
2025-03-07 | Grant | 90,000 | $0.00 | |
|
Aquestive Therapeutics Inc AQST
Common Stock
|
2024-06-07 | Grant | 25,000 | $0.00 |